ES2083387T3 - Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv. - Google Patents

Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.

Info

Publication number
ES2083387T3
ES2083387T3 ES89400221T ES89400221T ES2083387T3 ES 2083387 T3 ES2083387 T3 ES 2083387T3 ES 89400221 T ES89400221 T ES 89400221T ES 89400221 T ES89400221 T ES 89400221T ES 2083387 T3 ES2083387 T3 ES 2083387T3
Authority
ES
Spain
Prior art keywords
amino acid
hiv
begins
peptides
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89400221T
Other languages
English (en)
Other versions
ES2083387T5 (es
Inventor
Francesco Bellini
Gervais Dionne
Martial Lacroix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
IAF BioChem International Inc
Biochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27386744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2083387(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/148,821 external-priority patent/US6218102B1/en
Priority claimed from US07/281,205 external-priority patent/US6214537B1/en
Application filed by IAF BioChem International Inc, Biochem Pharma Inc filed Critical IAF BioChem International Inc
Publication of ES2083387T3 publication Critical patent/ES2083387T3/es
Application granted granted Critical
Publication of ES2083387T5 publication Critical patent/ES2083387T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE PROPORCIONAN PEPTIDOS CICLCOS DE FORMULA(I), EN LA QUE X ES EL EXTREMO AMINO, UN AMINOACIDO O SECUENCIA DE AMINOACIDO QUE EMPIEZA CON EL AMONOACIDO 604 Y LLEGA HASTA EL AMINOACIDO 586 (GP 41 - HIV - 1); E Y ES EL EXTREMO CARBOXILICO, UN AMINOACIDO O SECUENCIA AMINOACIDO QUE EMPIEZA CON EL AMINOACIDO 612 Y LLEGA HASTA EL AMINOACIDO 629 (GP 41 HIV - 1). TAMBIEN SE PROPORCIONAN PEPTIDOS DE FORMULA(II) EN LA QUE X1 ES EL EXTREMO AMINO, UN AMINOACIDO O SECUENCIA AMINOACIDO QUE EMPIEZA CON EL AMINOACIDO 596 Y LLEGA AL AMINOACIDO 578 (GP 42 - HIV - 2); E Y1 ES EL EXTREMO CARBOXILICO, UN AMINOACIDO O SECUENCIA AMINOACIDO QUE EMPIEZA CON EL AMINOACIDO 604 Y LLEGA HASTA EL 613 (GP 42 - HIV - 2). ESTOS PEPTIDOS CICLICOS SOLOS O EN MEZCLA CON DETERMINADOS PEPTIDOS LINEALES SON PARTICULARMENTE UTILES PARA LA DETECCION DE ANTICUERPOS.
ES89400221T 1988-01-27 1989-01-26 Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv. Expired - Lifetime ES2083387T5 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US148821 1988-01-27
US07/148,821 US6218102B1 (en) 1988-01-27 1988-01-27 Synthetic peptides and mixtures thereof for detecting HIV antibodies
US18551888A 1988-04-22 1988-04-22
US185518 1988-04-22
US281205 1988-12-07
US07/281,205 US6214537B1 (en) 1988-01-27 1988-12-08 Synthetic peptides and mixtures thereof for detecting HIV antibodies

Publications (2)

Publication Number Publication Date
ES2083387T3 true ES2083387T3 (es) 1996-04-16
ES2083387T5 ES2083387T5 (es) 2005-07-01

Family

ID=27386744

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89400221T Expired - Lifetime ES2083387T5 (es) 1988-01-27 1989-01-26 Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.

Country Status (7)

Country Link
EP (1) EP0326490B2 (es)
JP (3) JPH01224397A (es)
AT (1) ATE131492T1 (es)
AU (1) AU629528B2 (es)
DE (1) DE68925043T3 (es)
ES (1) ES2083387T5 (es)
IL (1) IL88963A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
GB8828097D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
GB8828098D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DE69129207T2 (de) * 1990-01-16 1998-10-08 Orgenics Ltd Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
AU7676891A (en) * 1990-04-03 1991-10-30 Genentech Inc. Hiv envelope polypeptides
NZ243636A (en) * 1991-07-29 1993-06-25 Iaf Biochem Int Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11
ATE179716T1 (de) * 1992-03-06 1999-05-15 Innogenetics Nv Verfahren zur bestimmung von peptiden, die immunologisch wichtigen epitopen von hcv zugehörig sind
CN1651457B (zh) * 1994-10-20 2010-07-28 巴斯德研究所 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
FR2874017B1 (fr) 2004-08-06 2006-11-24 Bio Rad Pasteur Sa Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
EP2778681A1 (en) * 2013-03-15 2014-09-17 Biomay Ag Method for diagnosing a viral infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
DE3887053T4 (de) * 1987-04-16 1994-09-08 Johnson & Johnson Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
JPH0215098A (ja) * 1987-05-18 1990-01-18 Virovahl Sa Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法
AU627701B2 (en) * 1987-10-28 1992-09-03 Euro-Diagnostica Ab Hiv peptides, artificial hiv antigens and immunoassay kits
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser

Also Published As

Publication number Publication date
JP2001055400A (ja) 2001-02-27
DE68925043T2 (de) 1996-08-22
EP0326490A3 (en) 1990-07-04
JP3851761B2 (ja) 2006-11-29
EP0326490A2 (en) 1989-08-02
EP0326490B1 (en) 1995-12-13
AU629528B2 (en) 1992-10-08
IL88963A0 (en) 1989-08-15
ATE131492T1 (de) 1995-12-15
ES2083387T5 (es) 2005-07-01
EP0326490B2 (en) 2004-11-24
IL88963A (en) 1996-05-14
DE68925043T3 (de) 2005-07-28
JPH08245693A (ja) 1996-09-24
JPH01224397A (ja) 1989-09-07
AU2851389A (en) 1989-07-27
DE68925043D1 (de) 1996-01-25

Similar Documents

Publication Publication Date Title
ES2083387T3 (es) Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
ES2123056T3 (es) Anticuerpo bnp e inmunoensayo que lo emplea.
DE68909345D1 (de) Verfahren und Kompositionen zur Erzeugung verstärkter Chemilumineszenz von 1,2-Dioxetanen.
ATE198754T1 (de) Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung
KR890000517A (ko) 하이브리드 단백질 c 및 이의 제조방법
ATE142789T1 (de) Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
ATE69108T1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
DK0498784T3 (da) Hæmmere af retroviral protease
EA200300678A1 (ru) Пептиды и/или белки, а также их применение для получения терапевтической и/или профилактической фармацевтической композиции
ES2098359T3 (es) Peptidos sinteticos y sus mezclas para detectar anticuerpos contra hiv.
ES8606411A1 (es) Procedimiento para la determinacion de fibrina
DE3884316D1 (de) Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung.
ATE133993T1 (de) Protein-antikrebsmittel
NO904129L (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.
ATE109468T1 (de) Verbindungen zur einführung einer sh-gruppe in tyrosin.
ATE20669T1 (de) Antigene lineare peptidverbindungen.
KR890001530A (ko) 지방산과 염기성 아미노산 혼합물의 생체 에너지원 대체
IT1248329B (it) Procedimento di dosaggio della tireoglobulina e corredo (kit) per la sua utilizzazione.
ES2017811A6 (es) Procedimiento de obtencion de una nueva proteina especifica de la gestacion de mamiferos y de anticuerpos policlonales y monoclonales de lamisma, utilizables en el diagnostico precoz de gestacion o de mortalidad embrionaria de mamiferos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 326490

Country of ref document: ES